Biogen investigated by Dutch antitrust regulator over Stratify test
US biotechnology Biogen is being probed by the Dutch competition authority over potential abuse of dominant position related to its anti-JCV test Stratify, the regulator told MLex. The ACM said it...To view the full article, register now.
Already a subscriber? Click here to view full article